Last update 01 Nov 2024
Zymenex A/S

Zymenex A/S

Subsidiary Company|
1998|
Denmark
|
10-50
|

Overview

Basic Info

Introduction
Zymenex is a biopharmaceutical company based in Scandinavia that specializes in creating innovative enzyme replacement therapies for the treatment of severe, inherited diseases. The company is currently working on developing various human recombinant enzymes that can be utilized in specific disease areas. These therapies aim to improve the quality of life and extend the life expectancy of patients who are currently suffering from debilitating conditions with limited treatment options. Enzyme replacement therapy is a well-established treatment method, and there are already several products on the market that support the company's approach. Zymenex's research and development efforts are focused on Lysosomal Storage Diseases, a group of disorders that hinder the body's ability to break down specific molecules in the lysosomes of cells. These diseases are often fatal, particularly in children, and there are currently no effective therapies available.

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
7
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
ACE-393
Diarrhea
More
Discontinued
ETEC vaccine(Acambis Plc)
Diarrhea
More
Discontinued
ACE-810
Moraxella Catarrhalis Infection
More
Pending
ACE-720
Pneumococcal Infections
More
Pending
G-0107
( Enzymes )
Genetic Diseases, Inborn
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free